The actions of benzophenanthridine alkaloids, piperonyl butoxide and (S)-methoprene at the G-protein coupled cannabinoid CB 1 receptor in vitro

European Journal of Pharmacology

Volumn 654, Issue 1, 2011, Pages 26-32

  Dhopeshwarkar, Amey S ^a   Jain, Saurabh ^a   Liao, Chengyong ^a   Ghose, Sudip K ^a   Bisset, Kathleen M ^a   Nicholson, Russell A ^a  

^a SIMON FRASER UNIVERSITY   (Canada)

Author keywords

CB 1 receptor; Chelerythrine; Methoprene; Mouse brain; Piperonyl butoxide; Sanguinarine

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; BERBERINE; CANNABINOID 1 RECEPTOR; CHELERYTHRINE; HYDRASTINE; METHOPRENE; PAPAVERINE; PIPERONYL BUTOXIDE; SANGUINARINE;

ANIMAL TISSUE; ARTICLE; BRAIN MEMBRANE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; DRUG RECEPTOR BINDING; IC 50; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ALKALOIDS; ANIMALS; BENZOPHENANTHRIDINES; BRAIN; DRUG INTERACTIONS; INHIBITORY CONCENTRATION 50; ISOQUINOLINES; MALE; METHOPRENE; MICE; PIPERIDINES; PIPERONYL BUTOXIDE; PROTEIN BINDING; PYRAZOLES; RECEPTOR, CANNABINOID, CB1;

EID: 78951470516     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.11.033     Document Type: Article

References (49)

1. E. Beausoleil, C. Chauvignac, T. Taverne, S. Lacombe, L. Pognante, B. Leblond, D. Pallares, C. De Oliveira, F. Bachelot, R. Carton, H. Peillon, S. Coutadeur, V. Picard, N. Lambeng, L. Desire, and F. Schweighoffer Structure-activity relationship of isoform selective inhibitors of Rac1/1b GTPase nucleotide binding Bioorg. Med. Chem. Lett. 19 2009 5594 5598
2. C.S. Breivogel, and S.R. Childers Cannabinoid agonist signal transduction in rat brain: Comparison of cannabinoid agonists in receptor binding, G-protein activation, and adenylyl cyclase inhibition J. Pharmacol. Exp. Ther. 295 2000 328 336
3. 1 receptor Eur. J. Pharmacol. 584 2008 338 342
4. V. Chevaleyre, K.A. Takahashi, and P.E. Castillo Endocannabinoid-mediated synaptic plasticity in the CNS Ann. Rev. Neurosci. 29 2006 37 76
5. 9-tetrahydrocannabinol J. Pharmacol. Exp. Ther. 263 1992 1118 1126
6. D.R. Compton, K.C. Rice, B.R. De Costa, R.K. Razdan, L.S. Melvin, M.R. Johnson, and B.R. Martin Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities J. Pharmacol. Exp. Ther. 265 1993 218 226
7. S.A. Deadwyler, R.E. Hampson, B.A. Bennett, T.A. Edwards, J. Mu, M.A. Pacheco, S.J. Ward, and S.R. Childers Cannabinoids modulate potassium current in cultured hippocampal neurons Recept. Channels 1 1993 121 134
8. W.A. Devane, F.A. Dysarz III, M.R. Johnson, L.S. Melvin, and A.C. Howlett Determination and characterization of a cannabinoid receptor in rat brain Mol. Pharmacol. 34 1988 605 613
9. W.S. Edgemond, W.B. Campbell, and C.J. Hillard The binding of novel phenolic derivatives of anandamide to brain cannabinoid receptors Prostaglandins Leukot. Essent. Fatty Acids 52 1995 83 86
10. 1 cannabinoid receptor J. Neurosci. 18 1998 2834 2841
11. D.R. Hawkins, K.T. Weston, L.F. Chasseaud, and E.R. Franklin Fate of methoprene (isopropyl(2E, 4E)-11-methoxy-3, 7, 11-trimethyl-2, 4-dodecadienoate) in rats J. Agric. Food Chem. 25 1977 398 403
12. C.A. Henrick Methoprene J. Amer. Mosq. Control Assoc. 23 2007 225 239
13. J.M. Herbert, J.M. Augereau, J. Gleye, and J.P. Maffrand Chelerythrine is a potent and specific inhibitor of protein kinase C Biochem. Biophys. Res. Commun. 172 1990 993 999
14. M. Herkenham, A.B. Lynn, M.R. Johnson, L.S. Melvin, B.R. de Costa, and K.C. Rice Characterization and localization of cannabinoid receptors in rat brain: A quantitative in vitro autoradiographic study J. Neurosci. 11 1991 563 583
15. D. Houston, and A. Howlett Solubilization of the cannabinoid receptor from rat brain and its functional interaction with guanine nucleotide-binding proteins Mol. Pharmacol. 43 1993 17 22
16. A.C. Howlett Cannabinoid inhibition of adenylate cyclase: Biochemistry of the response in neuroblastoma cell membranes Mol. Pharmacol. 27 1985 429 436
17. A.C. Howlett, and R.M. Fleming Cannabinoid inhibition of adenylate cyclase.: Pharmacology of the response in neuroblastoma cell membranes Mol. Pharmacol. 26 1984 532 538
18. i in the inhibition of adenylate cyclase by cannabimimetic drugs Mol. Pharmacol. 29 1986 307 313
19. A.C. Howlett, F. Barth, T.I. Bonner, G. Cabral, P. Casellas, W.A. Devane, C.C. Felder, M. Herkenham, K. Mackie, and B.R. Martin International Union of Pharmacology. XXVII. Classification of cannabinoid receptors Pharmacol. Rev. 54 2002 161 202
20. D.G. Jones Piperonyl Butoxide: The Insecticide Synergist 1998 Academic Press
21. 1 cannabinoid receptors regulate GABA release form axon terminals of specific hippocampal interneurons J. Neurosci. 19 1999 4555 4558
22. Y. Kawamura, M. Fukaya, T. Maejima, T. Yoshida, E. Miura, M. Watanabe, T. Ohno-Shosaku, and M. Kano The CB1 cannabinoid receptor is the major cannabinoid receptor at excitatory pre-synaptic sites in the hippocampus and cerebellum J. Neurosci. 26 2006 2991 3001
23. A. Kreitzer, and W. Regehr Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells Neuron 29 2001 717 727
24. 2+ currents by endocannabinoids released via postsynaptic mGluR activation at a Calyx synapse J. Neurosci. 24 2004 5955 5965
25. R. Lan, Q. Liu, P. Fan, S. Lin, S.R. Fernando, D. McCallion, R. Pertwee, and A. Makriyannis Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists J. Med. Chem. 42 1999 769 776
26. S.K. Lee, W.G. Qing, W. Mar, L. Luyengi, R.G. Mehta, K. Kawanishi, H.H.S. Fong, C.W.W. Beecher, A.D. Kinghorn, and J.M. Pezzuto Angoline and chelerythrine, benzophenanthridine alkaloids that do not inhibit protein kinase C J. Biol. Chem. 273 1998 19829 19833
27. K. Mackie, and B. Hille Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells Proc. Natl Acad. Sci. USA 89 1992 3825 3829
28. K. Mackie, Y. Lai, R. Westenbroek, and R. Mitchell Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor J. Neurosci. 15 1995 6552 6561
29. 1 receptor constitutes an agonist /inverse agonist binding region J. Med. Chem. 46 2003 5139 5152
30. D.K. Nomura, J.L. Blankman, G.M. Simon, K. Fujioka, R.S. Issa, A.M. Ward, B.F. Cravatt, and J.E. Casida Activation of the endocannabinoid system by organophosphorus nerve agents Nat. Chem. Biol. 4 2008 373 378
31. G.L. Peterson A simplification of the method of Lowry et al. which is more generally applicable Anal. Biochem. 83 1977 346 356
32. F. Petitet, B. Jeantaud, M. Capet, and A. Doble Interaction of brain cannabinoid receptors with guanine nucleotide binding protein; a radioligand binding study Biochem. Pharmacol. 54 1997 1267 1270
33. 1 receptor as a target for chlorpyrifos oxon and other organophosphorus pesticides Toxicol. Lett. 135 2002 89 93
34. G. Riedel, P. Fadda, S. McKillop-Smith, R.G. Pertwee, B. Platt, and L. Robinson Synthetic and plant-derived cannabinoid receptor antagonists show hypophagic properties in fasted and non-fasted mice Br. J. Pharmacol. 156 2009 1154 1166
35. M. Rinaldi-Carmona, F. Barth, M. Heaulme, D. Shire, B. Calandra, C. Congy, S. Martinez, J. Maruani, G. Neliat, D. Caput, P. Ferrara, P. Soubrie, J.C. Breliere, and G. Le Fur SR141716A a potent and selective antagonist of the brain cannabinoid receptor FEBS Lett. 350 1994 240 244
36. 2+ flux into N18TG2 neuroblastoma cells Mol. Brain Res. 120 2004 138 144
37. 35S]thio)triphosphate binding in rat brain membranes Life Sci. 59 1996 659 668
38. J.B. Siddall Insect growth regulators and insect control: A critical appraisal Environ. Health Perspect. 14 1976 119 126
39. I. Slalinova, E. Taborska, H. Bochorakova, and J. Slanina Interaction of benzo[c]phenanthridine and protoberberine alkaloids with animal and yeast cells Cell Biol. Toxicol. 17 2001 51 63
40. Z.-H. Song, and T.I. Bonner A lysine residue of the cannabinoid receptor is critical for receptor recognition by several agonists but not WIN55212-2 Mol. Pharmacol. 49 1996 891 896
41. 1 receptor Biochem. Pharmacol. 69 2005 169 178
42. G. Szabo, B. Varga, D. Payer-Lengyel, A. Szemzo, P. Erdelyi, K. Vukics, J. Szikra, E. Hegyi, M. Vastag, B. Kiss, J. Laszy, I. Gyertyn, and J. Fischer Chemical and biological investigation of cyclopropyl containing diaryl-pyrazole-3-carboxamides as novel and potent cannabinoid type 1 receptor antagonists J. Med. Chem. 2009 52 2009 4329 4337
43. 1 and CB2 receptor antagonist Br. J. Pharmacol. 146 2005 917 926
44. 1 receptors in the rat central nervous system Neuroscience 83 1998 393 411
45. W. Twitchell, S. Brown, and K. Mackie Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons J. Neurophysiol. 78 1997 43 50
46. M. Van der Stelt, J.A. Van Kuik, M. Bari, G. Van Zadelhoff, B.R. Leeflang, G.A. Veldink, A. Finazzi-Agro, J.F.G. Vliegenthart, and M. Maccarrone Oxygenated metabolites of anandamide and 2-arachidonoylglycerol: conformational analysis and interaction with cannabinoid receptors, membrane transporter, and fatty acid amide hydrolase J. Med. Chem. 45 2002 3709 3720
47. 2-selective agonists J. Pharmacol. Exp. Ther. 301 2002 679 689
48. R.A. Wilson, and R.I. Nicoll Endogenous cannabinoids mediate retrograde signaling at hippocampal synapses Nature 410 2001 588 592
49. C.H. Wu, M.S. Hung, J.S. Song, T.K. Yeh, M.C. Chou, C.M. Chu, J.J. Jan, M.T. Hsieh, S.L. Tseng, C.P. Chang, W.P. Hsieh, Y. Lin, Y.N. Yeh, W.L. Chung, C.W. Kuo, C.Y. Lin, H.S. Shy, Y.S. Chao, and K.S. Shia Discovery of 2-[5-(4-chlorophenyl)-1-(2, 4-dichlorophenyl)-4-ethyl-1H-pyrazol-3-yl]-1, 5, 5-trimethyl-1, 5-dihydroimidazol-4-thione (BPR-890) via an active metabolite. A novel, potent and selective cannabinoid-1 receptor inverse agonist with high antiobesity efficacy in DIO mice J. Med. Chem. 52 2009 4496 4510